
HQ - Tempe, Arizona
Summary
The transaction includes the transfer of manufacturing facilities, including multiple production lines, and 3.5 mL on-body injector technology to support production of current and next-generation AbbVie immunology and neuroscience medicines.
Deals Overview
All rights reserved. Copyright © 2026 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy